rik Heldin, European Federation of Pharmaceutical Industries Director-General Richard Bergstrom, and Microsoft Healthcare's chief development officer Mathias Ekman. Also among the expert speakers were Pfizer executive vice president and chief of the company’s worldwide research development Dr. Michael Dolsten,